{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:55:03Z","timestamp":1791143703650,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2014.00122","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T10:28:58Z","timestamp":1396520938000},"source":"Crossref","is-referenced-by-count":131,"title":["The future of vitamin D analogs"],"prefix":"10.3389","volume":"5","author":[{"given":"Carlien","family":"Leyssens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Verlinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Verstuyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1210\/endo-129-2-832","article-title":"A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia","volume":"129","author":"Abe","year":"1991","journal-title":"Endocrinology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF02050422","article-title":"Vitamin D3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model","volume":"40","author":"Akhter","year":"1997","journal-title":"Dis. Colon Rectum"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/archopht.122.9.1365","article-title":"Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model","volume":"122","author":"Albert","year":"2004a","journal-title":"Arch. Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/archopht.122.9.1357","article-title":"Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models","volume":"122","author":"Albert","year":"2004b","journal-title":"Arch. Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1158\/1078-0432.CCR-07-4274","article-title":"Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer","volume":"14","author":"Attia","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/cvr\/cvr133","article-title":"Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats","volume":"91","author":"Bae","year":"2011","journal-title":"Cardiovasc. Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4049\/jimmunol.1000695","article-title":"The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation","volume":"186","author":"Baeke","year":"2011","journal-title":"J. Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10637-012-9839-1","article-title":"Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studies","volume":"31","author":"Berkovich","year":"2013","journal-title":"Invest. New Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1158\/1535-7163.MCT-09-0064","article-title":"EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells","volume":"8","author":"Bhatia","year":"2009","journal-title":"Mol. Cancer Ther"},{"key":"B10","first-page":"779","article-title":"A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice","volume":"60","author":"Blutt","year":"2000","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0140-6736(91)90280-3","article-title":"Topical calcipotriol treatment in advanced breast cancer","volume":"337","author":"Bower","year":"1991","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.4161\/cc.24445","article-title":"Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo","volume":"12","author":"Chiang","year":"2013","journal-title":"Cell Cycle"},{"key":"B13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1053\/j.ajkd.2004.01.012","article-title":"Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4","volume":"43","author":"Coburn","year":"2004","journal-title":"Am. J. Kidney Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1210\/endo-108-3-1083","article-title":"1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture","volume":"108","author":"Colston","year":"1981","journal-title":"Endocrinology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD","volume":"47","author":"Coyne","year":"2006","journal-title":"Am. J. Kidney Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/sj.bjc.6601104","article-title":"A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma","volume":"89","author":"Dalhoff","year":"2003","journal-title":"Br. J. Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/(SICI)1097-4644(19961101)63:2199::AID-JCB73.0.CO;2-T","article-title":"Potent gene regulatory and antiproliferative activities of 20-methyl analogues of 1,25 dihydroxyvitamin D3","volume":"63","author":"Danielsson","year":"1996","journal-title":"J. Cell. Biochem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1210\/en.138.12.5485","article-title":"The vitamin D analog, KH1060, is rapidly degraded both in vivo and in vitro via several pathways: principal metabolites generated retain significant biological activity","volume":"138","author":"Dilworth","year":"1997","journal-title":"Endocrinology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","article-title":"A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response","volume":"153","author":"Ding","year":"2013","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2174\/092986707781058823","article-title":"Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs","volume":"14","author":"Eelen","year":"2007","journal-title":"Curr. Med. Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.chembiol.2008.08.008","article-title":"Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor","volume":"15","author":"Eelen","year":"2008","journal-title":"Chem. Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1124\/mol.104.008730","article-title":"Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction","volume":"67","author":"Eelen","year":"2005","journal-title":"Mol. Pharmacol"},{"key":"B23","first-page":"4412","article-title":"The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells","volume":"60","author":"El Abdaimi","year":"2000","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.bjc.6600162","article-title":"A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer","volume":"86","author":"Evans","year":"2002","journal-title":"Br. J. Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jss.2007.02.038","article-title":"A vitamin D analogue inhibits colonic carcinogenesis in the AOM\/DSS model","volume":"142","author":"Fichera","year":"2007","journal-title":"J. Surg. Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0960-0760(03)00028-1","article-title":"Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion","volume":"84","author":"Flanagan","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/pros.22644","article-title":"Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1alpha-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin","volume":"73","author":"Gee","year":"2013","journal-title":"Prostate"},{"key":"B28","first-page":"3757","article-title":"Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study","volume":"28","author":"Ghous","year":"2008","journal-title":"Anticancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1210\/en.2009-0650","article-title":"1 Alpha,25-dihydroxyvitamin D3 and its TX527 analog inhibit the growth of endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein-coupled receptor in vitro and in vivo","volume":"151","author":"Gonzalez-Pardo","year":"2010","journal-title":"Endocrinology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jsbmb.2004.03.039","article-title":"Gene expression profiles in dendritic cells conditioned by 1alpha,25-dihydroxyvitamin D3 analog","volume":"89\u00e2\u20ac\u201c90","author":"Griffin","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/archopht.120.5.607","article-title":"Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model","volume":"120","author":"Grostern","year":"2002","journal-title":"Arch. Ophthalmol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/bjc.1998.434","article-title":"A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer","volume":"78","author":"Gulliford","year":"1998","journal-title":"Br. J. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00774-012-0397-6","article-title":"Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis","volume":"31","author":"Hagino","year":"2013","journal-title":"J. Bone Miner. Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0006-2952(97)00181-0","article-title":"EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells","volume":"54","author":"Hansen","year":"1997","journal-title":"Biochem. Pharmacol"},{"key":"B36","first-page":"321","article-title":"Oral administration of 1 alpha hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model","volume":"21","author":"Hara","year":"2001","journal-title":"Anticancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jbmr.555","article-title":"Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone","volume":"27","author":"Harada","year":"2012","journal-title":"J. Bone Miner. Res"}],"container-title":["Frontiers in Physiology"],"original-title":[],"deposited":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T20:09:23Z","timestamp":1424290163000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphys.2014.00122\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3389\/fphys.2014.00122","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]}}}